Showing results (1541-1550 of 1,900) with videos related to

Sort By:
Pageof 190
Journal of Medicinal Chemistry|June 1, 2001
Potent and selective nonpeptide inhibitors of caspases 3 and 7D Lee, S A Long, J H Murray, et al.
Genes and Immunity|January 24, 2014
Plasmodium genetic loci linked to host cytokine and chemokine responsesS Pattaradilokrat, J Li, J Wu, et al.
Pediatric Blood & Cancer|September 29, 2025
Psychosocial Health and Chronic Health Conditions Among Bereaved Siblings: A Report From the Childhood Cancer Survivor Study (CCSS)Prachi Sharma, Nivya George, Deokumar Srivastava, et al.
Cell Reports. Medicine|August 2, 2021
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodiesAlexandra C Willcox, Alex S Huber, Ababacar Diouf, et al.
Plos One|September 11, 2019
Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activityJo-Anne Chan, David Wetzel, Linda Reiling, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2024
NAD activates olfactory receptor 1386 to regulate type I interferon responses in <i>Plasmodium yoelii</i> YM infectionYu-Chih Peng, Jian Wu, Xiao He, et al.
Archives of Pathology & Laboratory Medicine|April 11, 2019
Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the <i>BRAF</i>, <i>EGFR</i>, and <i>KRAS</i> Genes: A Study of the College of American Pathologists Molecular Oncology CommitteeJoel T Moncur, Angela N Bartley, Julia A Bridge, et al.
Scientific Reports|September 17, 2015
Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malariaDavid Llewellyn, Kazutoyo Miura, Michael P Fay, et al.
JAMA Oncology|December 16, 2017
Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS TestingAnnette S Kim, Angela N Bartley, Julia A Bridge, et al.
Vaccines|August 28, 2025
Year-Long Antibody Response to the EuCorVac-19 SARS-CoV-2 Vaccine in Healthy FilipinosJonathan F Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
Pageof 190